TrimRx's Blog
Mounjaro Shortage: When Will It End
The Mounjaro shortage was declared resolved by the FDA in December 2024, alongside Zepbound, which shares the same tirzepatide molecule.
Mounjaro Results After Week 1: Realistic Weight Loss Expectations
The first week on Mounjaro is mostly an adaptation week, not a weight loss week.
Mounjaro Results After Month 6: Realistic Weight Loss Expectations
Six months on Mounjaro is where the dual GIP/GLP-1 mechanism really separates from pure GLP-1 therapies.
Mounjaro Results After Month 3: Realistic Weight Loss Expectations
Three months on Mounjaro lands most patients at 9 to 12 percent body weight loss and 2 to 3 dose escalations into the protocol.
Mounjaro Results After Month 2: Realistic Weight Loss Expectations
Month 2 on Mounjaro is when most patients stop questioning whether the medication is working.
Mounjaro Results After 1 Year: Realistic Weight Loss Expectations
A year on Mounjaro is the data point that reshaped the GLP-1 landscape. SURMOUNT-1 (Jastreboff et al.
Mounjaro Results After Month 1: Realistic Weight Loss Expectations
One month on Mounjaro is the first real signal that the medication is working.
Mounjaro Rash: Skin Reactions Explained
Tirzepatide trials told us early that injection-site reactions would be more common with Mounjaro than with older GLP-1 drugs.
Mounjaro Muscle Loss: Real Risk and Mitigation
Introduction Mounjaro® causes substantial weight loss in adults with type 2 diabetes (SURPASS program) and obesity-dose tirzepatide (Zepbound®) produces even more (20.9% mean at…
